Ernst Heinen Net Worth & Insider Trades

Ernst Heinen - Chief Development Officer, Aratana Therapeutics, Inc

As of July 18, 2019

What is Ernst Heinen's Net Worth?

The current estimated net worth of Aratana Therapeutics, Inc's Chief Development Officer, Ernst Heinen, is estimated to be about $869.65K . Ernst Heinen owns about 135,694 units of Aratana Therapeutics, Inc common stock. In the last 6 years at Aratana Therapeutics, Inc, Ernst Heinen has sold an estimated value of $869.65K worth.

What is Ernst Heinen's Past Insider Trading?

Ernst Heinen's largest sale order was 15,000 units , worth over $255.83K on July 17, 2015. In total, Ernst Heinen has made about 17 transactions over 6 years of their time at Aratana Therapeutics, Inc. Ernst Heinen usually trades in January, with the busiest year in 2018. The most recent transaction was a sale order of 19,308 units , worth over $134.19K on November 9, 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Ernst Heinen's' Mailing Address?

  • Mailing address is C/o Aratana Therapeutics, Inc. 11400 Tomahawk Creek Parkway, Suite 340 Leawood KS 66211 KS

Aratana Therapeutics, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Steven St. Peter, M.D. 2018 $528,390 $654,948 $649,006 $247,000 $11,000 $2,090,344
Steven St. Peter, M.D. 2017 $513,000 $1,121,998 $982,434 $213,000 $10,800 $2,841,232
Craig A. Tooman 2018 $360,000 $191,751 $189,953 $110,900 $11,000 $863,604
Craig A. Tooman 2017 $360,000 $245,412 $238,970 $95,100 $10,800 $950,282
Brent Standridge 2018 $315,000 $191,751 $189,953 $92,100 $11,000 $799,804
Brent Standridge 2017 $307,500 $109,072 $106,209 $81,300 $10,800 $614,881
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1509190/000150919019000027/petx-20190419xdef14a.htm

What are Aratana Therapeutics, Inc's Past Insider Trades?

Aratana Therapeutics, Inc's most recent insider trade came on February 1, 2019 by John C Ayres who sold 3,125 units worth $13.09K . In the last 6 years, insiders at Aratana Therapeutics, Inc have sold an estimated value of $68.33M and bought an estimated value of $12.01M worth of shares. Insider trading is most common in June, with the busiest year in 2014. The most active traders at the company are StSt, PRESIDENT AND CEO,  Ernst Heinen, Chief Development Officer,  and Julia A Stephanus, CHIEF COMMERCIAL OFFICER .

ARATANA THERAPEUTICS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1